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Abstract
More than one in three adults worldwide is either overweight or obese. Epidemiological studies indicate that the location
and distribution of excess fat, rather than general adiposity, are more informative for predicting risk of obesity sequelae,
including cardiometabolic disease and cancer. We performed a genome-wide association study meta-analysis of body fat
distribution, measured by waist-to-hip ratio (WHR) adjusted for body mass index (WHRadjBMI), and identified 463 signals in
346 loci. Heritability and variant effects were generally stronger in women than men, and we found approximately one-third
of all signals to be sexually dimorphic. The 5% of individuals carrying the most WHRadjBMI-increasing alleles were
1.62 times more likely than the bottom 5% to have a WHR above the thresholds used for metabolic syndrome. These data,
made publicly available, will inform the biology of body fat distribution and its relationship with disease.
Introduction
Approximately 39% of adults worldwide is either overweight or
obese (1,2) and is at increased risk of metabolic disease. While
higher adiposity increases morbidity and mortality (1,3), epi-
demiological studies indicate that the location and distribution
of excess fat within particular depots are more informative than
general adiposity for predicting disease risk. Independent of
their overall bodymass index (BMI), individuals with higher cen-
tral adiposity have increased risk of cardiometabolic diseases,
including type 2 diabetes (T2D) and stroke (4,5); in contrast,
individuals with higher gluteal adiposity have lower risk of such
outcomes (5). Previous studies indicate that fat distribution, as
assessed by waist-to-hip ratio (WHR), is a trait with a strong her-
itable component, independent of overall adiposity (measured
by BMI), with twin-based heritability estimates ranging between
30% and 60% (5,6), and narrow-sense heritability estimates have
been estimated at ∼50% in women and ∼20% in men (5). The
most recent genome-wide association study (GWAS) in 224 459
samples implicated 49 loci associated with WHR adjusted for
BMI (WHRadjBMI) (5), and recentMendelian randomization stud-
ies using knownWHR-associated genetic variants showed puta-
tive causal effects of higher WHR on T2D and coronary artery
disease independent of BMI (7).
Results
With the goal of pinpointing genetic variants associated to
body shape and fat distribution and motivated by the recent
release of genetic data from half a million individuals (8), we
performed a meta-analysis of WHRadjBMI. WHRadjBMI is an
easily-measured fat distribution phenotype that correlates well
with imaging-based fat distribution measures (9).We performed
GWAS of WHRadjBMI in the UK Biobank data set (8), a collection
of 484 563 samples with densely imputed genotype data, using
a linear mixed model (LMM) (10) to account for relatedness
and ancestral heterogeneity. We then combined the results
with publicly available GWAS data generated by the Genetic
Investigation of ANthropometric Traits (GIANT) consortium for
the same phenotype (Table 1 and Methods) (5), resulting in a
meta-analysis of 694 649 samples (Table 1) and ∼27.4M single-
nucleotide polymorphisms (SNPs) (Methods). As a sensitivity
analysis and to evaluate the robustness of our results, we also
performed a GWAS of WHR unadjusted for BMI (Table 1).
We identified 346 loci (300 novel) containing 463 independent
signals associated with WHRadjBMI [P < 5 × 10−9, to account
for the denser imputation data (11); Methods, Supplementary
Material, Table 1 and SupplementaryMaterial, Fig. 1]. The linkage
disequilibrium (LD) score regression (12) intercept (1.035) of the
meta-analysis results indicated that the observed enrichment in
genomic signal was due to polygenicity and not confounding
(Supplementary Material, Table 2). Of the 300 novel signals,
234 (78%, Pbinomial < 1 × 10−7) were directionally consistent in
an independent dataset with a relatively small sample size
(N = 7721), and signals were consistent in several sensitivity
checks (Supplementary Material, Tables 3–5 and Supplementary
Material, Figs 2–3). Combined, these variants explained ∼3.9% of
the variance in WHRadjBMI in the independent study (Methods
and Table 1). We constructed a weighted polygenic risk score
(PRS) using the 346 index SNPs discovered in the combinedmeta-
analysis and tested this score in the same independent study.
The 5% of individuals carrying the most WHRadjBMI-raising
alleles were 1.62 times more likely to meet the WHR threshold
used to definemetabolic syndrome (13) than the 5% carrying the
fewest (consistent with the results obtained from unweighted
polygenic score; Methods). The WHRadjBMI of people in the
top 5% of the PRS was 1.05 and 1.06 times greater in men and
women, respectively, compared to those in the bottom 5% of
the PRS.
To investigate the potential for collider bias resulting
from conditioning WHR on BMI, we investigated the behavior
of WHRadjBMI-associated SNPs in GWAS of WHR (without
adjustment for BMI) and BMI alone. We found that the majority
of WHRadjBMI signals identified has genuine effect on body
shape and that any bias caused by adjusting WHR for a
correlated covariate (14,15) (that is, BMI) was minimal. Of the
346 index variants, 311 associated with stronger standard
deviation effect sizes for WHR (unadjusted) than with standard
deviation effect sizes for BMI (Supplementary Material, Table
3 and Supplementary Material, Fig. 4). This observation also
indicates that the WHR association is unlikely to be secondary
to the known effect of higher BMI resulting in higher WHR.
Furthermore, the common SNP associated with the largest
known effect on BMI, that in the FTO gene (16), was not
associated with WHRadjBMI (rs1421085, P = 0.40) despite a
very strong association with WHR (P = 4 × 10−118)). Finally,
carrying each additional (weighted) WHRadjBMI-raising allele
was associated with an increase in WHRadjBMI of 0.0199 SD
(P = 6 × 10−62; adjusted R2 = 4%), an increase in WHR of 0.011
SD (P = 3 × 10−20; adjusted R2 = 0.12%) and a decrease in
BMI of 0.004 SD (P = 1.4 × 10−3; adjusted R2 = 0.13%) in our
independent dataset, consistent with the results obtained from
an unweighted polygenic score (Methods).
Given the sex dimorphism of fat distribution in humans, pre-
viously shown to have a genetic basis (5,17), we next performed
meta-analyses of WHRadjBMI in women and men separately
(Table 1 and Supplementary Material, Fig. 5). We found SNP-
based heritability (h2g) of WHRadjBMI, estimated using the
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Table 1. Large-scale meta-analysis in body fat distribution
Phenotype Sex Sample sizes Associated loci
P < 5 × 10 −9
Dimorphic
index SNPs
(% of total)
h2g (se) Variance
explained
UKBB GIANT Meta Loci Independent
signals
Combined 484 563 210 086 694 649 346 463 53 (15.3) 0.174 (0.002) 3.9%
WHRadjBMI Women 262 759 116 742 379 501 266 363 77 (28.9) 0.256 (0.003) 3.6%
Men 221 804 93 480 315 284 91 102 13 (14.3) 0.167 (0.003) 1.0%
Combined 485 486 212 248 697 734 316 382 37 (11.7) 0.194 (0.002) 3.0%
WHR Women 263 148 118 004 381 152 203 261 64 (31.5) 0.254 (0.003) 4.0%
Men 222 338 94 434 316 772 79 82 10 (12.7) 0.208 (0.003) 0.3%
We performed a meta-analysis of fat distribution as measured by WHRadjBMI in up to 694 649 individuals. We performed analyses of WHR as a sensitivity measure.
Our analyses increase the number ofWHRadjBMI-associated loci (P < 5 × 10−9, to account for SNP density in UK Biobank) to 346 loci. SNP-based heritability (h2g ) results,
estimated using the REML method implemented (10), and top-associated loci indicate patterns of sex dimorphism. The top-associated index SNPs explain 3.9% of the
overall phenotypic variance (i.e. adjusted R2) in fat distribution (calculated in an independent dataset, N = 7721).
Figure 1. Sex-dimorphic association signals in fat distribution. For each associated locus from either the combined or sex-specific meta-analyses, we tested the
index SNP for sex dimorphism. We plot here all index SNPs from each of the three meta-analyses (combined, women only and men only). SNPs that are significantly
sex-dimorphic (Pdiff < 3.3 × 10−5) are represented by boldly colored circles, while index SNPs that are not sex-dimorphic are plotted with faded colors. Despite the
expectation that SNPs identified in the combined sample (men and women, grey points) will be biased away from sex dimorphism and index SNPs identified in the
sex-specific sample will be biased towards sex dimorphism (due to winner’s curse), we observed stronger effects in women across all SNPs. Of the index SNPs from the
men-only analysis (orange points), 14% showed evidence of sex dimorphism. In contrast, ∼29% of the index SNPs from the women-only analysis (blue points) show
evidence of dimorphism.Of all sex-dimorphic SNPs, 92.4% showa stronger effect inwomen compared tomen.Points are sized by the -log10(Pdiff) of the sex-dimorphism
test. Horizontal bars indicate standard error in men; vertical bars indicate standard error in women.
restricted maximum likelihood (REML) method implemented in
BOLT-REML (10) (Methods), to be stronger in women (h2g = 25.6%)
compared to men (h2g = 16.7%, Pdifference = 9 × 10−85; Table 1,
Supplementary Material, Table 6, and Equation 2). In addition
to the heritability dimorphism, and in keeping with previous
studies (5), we found signatures of sex dimorphism among
associated loci: a total of 266 loci associated with WHRadjBMI in
women, compared to 91 loci in men (P < 5 × 10−9). Genome-
wide, SNP effects on WHRadjBMI were strongly correlated
between men and women [LD Score rg = 0.514 (s.e. = 0.019),
P = 3.43 × 10−159], but the consistency between the effect
size of 266 female index SNPs on WHRadjBMI in women and
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men (adjusted R2 = 51%) was greater than the consistency
between the effect size of 91 male index SNPs on WHRadjBMI
in men and women (adjusted R2 = 9%). Of all associated index
SNPs (P < 5 × 10−9 in the combined or sex-specific analyses),
105 SNPs were sex-dimorphic [Pdiff < 3.3 × 10−5; (17) and
Methods]. Variants discovered in the combined sex analysis
will be enriched for those with similar effects in each sex, while
variants discovered in sex-specific analyses will be enriched for
those with differing effects between sexes. In the absence of any
sex-specific effects, we would only expect a slight shift towards
stronger associations in women due to the larger available
sample size in that analysis. However, we observed that of the
105 sex-dimorphic signals, 97 (92.4%) showed stronger effects in
women compared to men (Fig. 1, Supplementary Material, Fig. 6
and Methods). Scanning genome-wide for sex-dimorphic SNPs
(Pdiff < 5 × 10−9), regardless of their association P-values in the
sex-specific analyses, we identified 61 sex-dimorphic SNPs after
LD-based clumping (r2 < 0.05). Of these, 19 (31.1%) overlapped
with the sex-dimorphic and genome-wide significant loci,
and 54 (88.5%) had stronger effect in women than in men
(Supplementary Material, Information).
Previous studies have shown that in addition to redis-
tributing body fat, some WHRadjBMI variants are also asso-
ciated with total body fat percentage (BF%) (5,18–20). Of
relevance to the biology of adipose tissue storage capacity,
these studies have shown that these pleiotropic associa-
tions can occur in both directions: some alleles associated
with higher WHRadjBMI are associated with higher total
BF%, while others are associated with lower BF% (5,18–20).
To test the hypothesis that alleles associated with higher
WHRadjBMI could have pleiotropic effects on total BF% and
that these effects could occur in both directions, we next
investigated whether 346 index variants associated with
WHRadjBMI also associated with BF%. Of the 59 of 346
variants associated with BF% in 443 001 European-ancestry
UK Biobank individuals (P < 0.05/346 = 1.44 × 10−4), 25 SNPs
associated with higher WHR and higher BF%, while 34 SNPs
associated with higher WHR but lower BF% (Fig. 2). These
findings indicate that WHR-increasing alleles do not strictly
influence BF% in one direction but rather can associate with
either higher or lower BF%, yielding biological insight beyond
the known epidemiological correlation between BF% and
WHR. Additionally, a large proportion (29%) of WHRadjBMI
index SNPs with a stronger effect in women had a BF%
phenotype in men: 28 of the 97 female-specific WHRad-
jBMI SNPs were associated with BF% in men, and 25 were
associated with BF% in women (P < 0.05/105 = 4.8 × 10−4;
Supplementary Material, Fig. 7). These variants appear to alter
total BF% in men and women to a similar extent but distribute
body fat between the upper and lower body to a much greater
extent in women (Supplementary Material, Table 7–9 and
Supplementary Material, Fig. 7). Finally, we tested the index
SNPs from each of the meta-analyses (combined and sex-
specific) in a recent GWAS of computed tomography (CT) and
magnetic resonance imaging (MRI) image-based measures of
ectopic and subcutaneous fat depots (21). Adjusting for the
three sample groups and the eight depots examined in the
imaging-based GWAS (P < 0.05/24 = 2.1 × 10−3), the alleles
associated with higher WHRadjBMI were collectively associated
with lower measures of subcutaneous fat and higher measures
of visceral fat, including pericardial and visceral adipose tissue
(Supplementary Material, Fig. 8).
Figure 2. Effects of WHRadjBMI-associated SNPs on body fat percentage. (A) We investigated the impact of the 346WHRadjBMI index SNPs (discovered in the combined
analysis) on BF% in 449 001 UK Biobank individuals. Of the 346 SNPs, 59 (17.1%) are associated with BF% (P < 0.05/346 = 1.44 × 10−4, dark grey points). We oriented the
effects of the SNPs to the WHRadjBMI-increasing effect and found that 34 of the 59 BF%-associated SNPs associate with increased BF%, while 25 of the 59 associate
with decreased BF%, indicating that WHRadjBMI-associated SNPs can affect BF% in both directions. (B) Given the sex-dimorphic signature observed in WHRadjBMI-
associated SNPs and the increased number of SNPs with stronger effects on WHRadjBMI in women, we investigated the effect of the 105 sex-dimorphic index SNPs
identified from the three meta-analyses (in the combined sample, in women only, in men only) on BF% in men or women separately. Of the 105 dimorphic SNPs, 97
were female specific (aquamarine points) and conferred a stronger effect on WHRadjBMI (on average) compared to the eight male-specific SNPs (orange points). We
plot the 105 sex-dimorphic SNPs by their effect on BF% in men (x-axis) and in women (y-axis). Of the 105 SNPs, 56 associate with BF% (P < 0.05/05 = 4.8 × 10−3). Despite
the fact that these SNPs confer different effects on WHRadjBMI within sex-specific groups, we found that they confer relatively similar effects in BF% in sex-specific
groups. All points are scaled in size to their strength of association in BF%.
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Discussion
In a meta-analysis of nearly 700 000 individuals, we have
increased the number of loci associated to WHRadjBMI by
more than 7-fold. Of all the detected signals, 105 are sex-
dimorphic, consistent with previous findings (5). While we have
performed the largest meta-analysis of a measure of body fat
distribution to date, a number of limitations remain. First, the
substantially larger number of signals with a stronger effect in
women compared to men may be influenced by the reduction
in power (proportional to the product of sample size and SNP
heritability) in the men-only analysis (Table 1) compared to the
women-only analysis. Despite the power difference in the sex-
specific analyses, we would not expect the difference to result
in 92% of signals conferring a stronger effect in women. Second,
our replication sample was too small (∼1% of the discovery) to
formally replicate individual SNP associations, but the fact that
78% of the 300 previously unknown index associations showed
consistent direction of effect suggests a low false-positive rate.
Finally, our meta-analysis focused only on European-ancestry
samples. Given the very different body fat distributions observed
across ancestral groups, and the very different risks of adiposity-
related disease across populations, studies in non-Europeans are
urgently needed (22,23).
In summary, the genetic variants and loci identified by this
meta-analysis will likely provide starting points for further
understanding the biology of body fat distribution and its
relationship with disease.
Materials and Methods
Data and code availability
Code and data related to this project, including summary-
level data from the meta-analyses, can be found online at
https://github.com/lindgrengroup/fatdistnGWAS.
Phenotypes
To generate phenotypes for the WHR and WHRadjBMI analyses
in the UK Biobank data (Supplementary Material, Table 10),
we followed a phenotype conversion consistent with that per-
formed in previous efforts investigating WHR and WHRadjBMI
by the GIANT consortium (5,24).
Using phenotype information from UK Biobank, we divided
waist circumference by hip circumference to calculate the WHR
measure, and then regressed the WHR measure on sex, age at
assessment, age at assessment squared and assessment centre.
To generate the WHRadjBMI phenotype, we followed the same
procedure and included BMI as an additional independent vari-
able in the regression.We performed rank inverse normalization
on the resulting residuals from the regression (Supplementary
Material, Fig. 9) and used these normalized residuals as the
tested phenotype in downstream genome-wide association test-
ing. To generate phenotypes for the sex-specific analyses, we
followed this same procedure but ran the regressions in sex-
specific groups.
Genome-wide association analyses
The UK Biobank data. We conducted genome-wide association
testing in the second release (June 2017) version of the UK
Biobank data (8); this release did not contain the corrected
imputation at non-Haplotype Reference Consortium [HRC (25)]
sites, and we therefore subset all of the SNP data down to HRC
SNPs only. The UK Biobank applied quality control to samples
and genotypes and imputed the resulting genotype data using
sequencing-based imputation reference panels. We performed
all of our genome-wide association testing and downstream
analyses on the publicly available imputation data (released in
bgen format).
We excluded samples as suggested by the UK Biobank upon
release of the data (Supplementary Material, Table 11). Sample
exclusions included samples with genotype but no imputation
information, samples with missingness >5%, samples with mis-
matching phenotypic and genotypic sex and samples that have
withdrawn consent since the initiation of the project.
LD scores and genetic relationship matrix for BOLT-LMM. We
implemented all GWAS in BOLT-LMM (10), which performs asso-
ciation testing using an LMM. To run, BOLT-LMM requires three
primary components: the (imputed) genotypic data for associ-
ation testing; a reference panel of LD scores per SNP, calcu-
lated using LD Score Regression (12); and genotype data used to
approximate a genetic relationship matrix (GRM), which is the
bestmethod available in this sample size to account for all forms
of relatedness, ancestral heterogeneity in the samples and other
(potentially hidden) structure in the data.
We performed sensitivity testing (Supplementary Material,
Information, Supplementary Material, Tables 12–13 and Sup-
plementary Material, Fig. 10) using three LD Score reference
datasets and four SNP sets to construct the GRM. For our
final GWAS, we used LD scores calculated from a randomly
selected 9748 unrelated UK Biobank samples (∼2% of the full UK
Biobank sample set; Supplementary Material, Information) and
a GRM constructed using imputed SNPs with imputation info
score > 0.8, minor allele frequency (MAF) > 1%, Hardy Weinberg
P-value > 1 × 10−8, genotype missingness < 1%, after converting
imputed dosages to best-guess genotypes, LD pruned at a
threshold (r2) of 0.2, and excluding the major histocompatibility
complex, the lactase locus and the inversions on chromosomes
8 and 17 (Supplementary Material, Information).
Association testing. For genome-wide association testing, we
used BOLT-LMM to run an LMM.We tested SNPs with imputation
quality (info)> 0.3,MAF> 0.01% (equivalent to∼100 copies of the
minor allele in the full sample), and only those single-nucleotide
variants and SNPs represented in the HRC (25) imputation refer-
ence panel.We used only the standard LMM implementation (i.e.
infinitesimal model, using l mm) in BOLT-LMM (Supplementary
Material, Figs 11–12); we did not run association testing using
a non-infinitesimal model. The only covariate used in the LMM
was the SNP array used to genotype sample; we included no
other covariates.
After association testing, we looked at known SNPs already
reported in WHR, WHRadjBMI and BMI (5,24). At the previously-
described loci, we checked correlation of frequency, beta, stan-
dard error and -log10(P-value) between our UK Biobank GWAS
and the previous GWAS results (SupplementaryMaterial, Fig. 13).
Additionally, we estimated genomic inflation (lambda) and the
LD Score Intercept to check if the P-values were well calibrated
(Supplementary Material, Table 2); calculations were performed
using the LD Score software (https://github.com/bulik/ldsc) (12).
Meta-analysis of results from UK Biobank and GIANT
Data preparation and quality control. Wedownloaded summary-
level results from previous meta-analyses of WHR and
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WHRadjBMI (https://portals.broadinstitute.org/collaboration/
giant/index.php/GIANT consortium data files and Supplemen-
tary Material, Information) performed by the GIANT consortium
(5). Marker names in both the GIANT data and UK Biobank
were lifted over to their dbSNP151 identifier. We additionally
renamedmarkers as ‘rsID:A1:A2’ (where A1 was the tested allele
in UK Biobank) to avoid ambiguity at multiallelic SNPs in the UK
Biobank data. As the GIANT data was imputed with HapMap 2
(26,27) data (hg18), we additionally lifted chromosomal positions
to hg19 for this data. SNPs with a frequency difference > 15%
between GIANT and UK Biobank were removed from the data
(Supplementary Material, Fig. 14).
Meta-analysis and downstream quality control. We performed
inverse variance-weighted fixed effects meta-analysis in
METAL (28). To estimate LD score intercepts and genomic
inflation (lambda) for the meta-analysis results, we first
estimated LD scores from the same samples used to estimate the
LD score reference for BOLT-LMM. LD scores were only estimated
at high-quality SNPs (using the same criteria as used for SNPs
included in the GRM in BOLT-LMM, but without applying a
MAF threshold; Supplementary Material, Information). We then
calculated LD Score Regression intercepts and lambda with the
LDSC software (12).
As an additional quality control check, we reran all of our
GWAS using two different subsets of the UK Biobank samples:
(1) the unrelated samples only and (2) the unrelated white
British samples only. These subsamples were selected to test if
our initial UK Biobank–wide GWAS was confounded by either
relatedness or ancestral heterogeneity. After running these
GWAS, we meta-analyzed the results with the existing GIANT
summary-level data and checked the concordance of our signals
(Supplementary Material, Figs 2–3).
Identification of index and secondary signals
LD clumping. To identify genomic loci (i.e. genomic windows)
containing independent association signals,we first constructed
a reference dataset of best-guess genotypes from 20 275
unrelatedUKBiobank samples (equivalent to 5% of the unrelated
sample). We converted imputed dosages of SNPs with info
score > 0.3 and MAF > 0.001% to best-guess genotypes using
PLINK (version 1.9) (29,30) and a conversion threshold (hard-call-
threshold) of 0.1 (Supplementary Material, Information). SNPs
with missingness > 5% after conversion or Hardy–Weinberg
equilibrium P < 1 × 10−7 were removed.
We then used the PLINK ‘clumping’ algorithm to select top-
associated SNPs (P < 5 × 10−9) and identify all SNPs in LD
(r2 > 0.05) with the top associated SNP and ±5 Mb away. We
determined the genomic span of each LD-based clump and
added 1 kb up- and downstream as buffer to the region. If any
of these windows overlapped, we merged them together into a
single (larger) locus. As a sensitivity analysis, we ran clumping
also using a smaller genomic window to calculate LD (±2 Mb);
the results were effectively unchanged, as<5 loci appeared inde-
pendent using the ±2 Mb window but were found to correlate
using ±5 Mb windows. Therefore, we report loci using the ±5 Mb
window.
Proximal conditional and joint testing. To identify index and
secondary signalswithin each of the clumping-based loci,we ran
proximal joint and conditional analysis as implemented in the
Genome-wide Complex Trait Analysis (GCTA) software (31). We
ran this model (cojo-slct) using the summary-level data within
each locus, the LD reference panel constructed from UK Biobank
data and also used for the locus ‘clumping’, and setting genome-
wide significance with P < 5 × 10−9.
Validation in an independent dataset
We used an independent dataset EXTEND (7721 individuals
of European descent collected from South West England,
Supplementary Material, Table 14) to validate our findings. We
extracted the index SNPs from the HRC-imputed genotypes. To
generate the WHRadjBMI variable, we regressed WHR on BMI,
age, age-squared, sex and principal components 1–5. We then
performed rank-based inverse normalization on the resulting
residuals. We validated the findings in three steps:
(1) Directional consistency. We checked for directional consis-
tency between the effect of index SNPs on WHRadjBMI from the
main meta-analysis and EXTEND. We performed linear regres-
sion of WHRadjBMI on each individual SNP. We ensured all
alleles were aligned to the WHRadjBMI-increasing allele in the
original meta-analysis. We compared directions between all 346
index SNPs and then split these into novel and known signals
to determine the number of novel signals showing consistent
directionality.
(2) Variance explained.Weevaluated the proportion of variance
explained by including all the index SNPs into a linear regression
model and calculated the adjusted R2.We performed these anal-
yses using the lm() function in R.
(3) Polygenic scores. We created a weighted polygenic score
based on the 346 index SNPs associated with WHRadjBMI. The
weighted PRS was calculated by summing the dosage of the
WHRadjBMI-increasing alleles (weighted by the effect size on
WHRadjBMI from the meta-analysis). We then performed linear
regression to test the association between WHRadjBMI and the
PRS in our independent dataset.
We sought to determine how likely the 5% of individuals
carrying the most WHRadjBMI-increasing alleles were to meet
the World Health Organization (WHO) WHR threshold used to
diagnose metabolic syndrome (along with lipids and T2D status)
(13) compared to the 5% carrying the least.We used theWHR ref-
erence levels of >0.9 in men and >0.85 in women to define cases
and WHR <0.9 in men and <0.85 in women to define controls
(13). We excluded all individuals with missing data, leaving a
sample size of 7513.We took 5% of individuals (7513× 0.05= 376)
from the two ends of weighted PRS and coded them as 1 or 2.We
tested for the likelihood of the top 5% meeting the WHR thresh-
old to diagnosemetabolic syndrome (WHO criteria) compared to
the bottom 5% using a binomial logistic regressionmodel adjust-
ing for age, age-squared, sex and principal components 1–5.
Collider bias analysis
Given that we had conditioned WHR on the BMI phenotype for
analysis (and BMI and WHR are correlated; r = 0.433 in the UK
Biobank data; Supplementary Material, Fig. 15), we tested all
index signals found in the WHRadjBMI analysis for evidence of
collider bias (15,32). To do this, we ran meta-analyses of BMI and
WHR using the UK Biobank samples and pre-existing summary-
level data from GIANT (5,24) (Supplementary Material,Methods).
We performed these meta-analyses using identical methods to
the meta-analysis of WHRadjBMI.
Then, for each index SNP from the WHRadjBMI meta-
analyses (combined as well as sex-specific), we extracted the
association results from the BMI and WHR meta-analyses
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(Supplementary Material, Fig. 4). WHRadjBMI-associated SNPs
with a stronger association for BMI than WHR show evidence of
collider bias or pleiotropy. We additionally looked at the effect
size and direction of effect in BMI and WHR, but whether the
effects are from collider bias or pleiotropy cannot be determined
from this data.
Identification of sex-dimorphic signals
We estimated correlation between WHRadjBMI in females and
in males using bivariate LD score regression analysis (12,33).
We performed sex-specific GWAS in UK Biobank and meta-
analyzed the results with publicly available sex-specific data
from the GIANT consortium.We identified the primary and sec-
ondary signals from these meta-analyses using methods iden-
tical to those performed in the combined analysis. We tested
each primary and secondary signal for a sex-dimorphic effect
by estimating the t-statistic
t = βfemales − βmales√
se2females + se 2males − 2r ∗ sefemales ∗ semales
(1)
where se is the standard error and r is the genome-wide Spear-
man rank correlation coefficient between SNP effects in females
and males. We estimated the t-statistic and the resulting so-
called Pdiff (P-value from a t-distribution (17)) as implemented in
the EasyStrata software (34).
We tested a total of 2162 different index SNPs for sex dimor-
phism; we tested all of the secondary signals as well, but these
signals are by definition in LDwith the index SNPs (and therefore
not independent). Given that we tested for sex dimorphism at
index SNPs in not only WHRadjBMI but WHR and BMI as well,
we performed a test at 1502 distinct genomic loci. Therefore, we
set significance for sex dimorphism at a Bonferroni-corrected
P = 0.05/1502 = 3.3 × 10−5.
SNPs were determined to have a stronger effect in women
if they fell into one of the following categories (abs, absolute
value):
a. betafemales ≤ 0 and betamales ≤ 0 and abs(betafemales)
> abs(betamales)
b. betafemales ≥ 0 and betamales ≥ 0 and abs(betafemales)
> abs(betamales)
c. betafemales ≤ 0 and betamales ≥ 0 and Pfemales < Pmales and
abs(betafemales) > abs(betamales), or
d. betafemales ≥ 0 and betamales ≤ 0 and Pfemales < Pmales and
abs(betafemales) > abs(betamales)
Heritability calculations
SNP-based heritability calculations. We implemented all heri-
tability calculations in BOLT-LMM (10). We used the same GRM
to estimate SNP-based heritability as we did to run our GWAS
(seeGenome-wide association analyses). This GRM included 790 000
SNPs.Heritabilitywas estimated using only the UK Biobank sam-
ples, for which we had individual-level data; these estimates are
likely more accurate than those resulting from only summary-
level data. We used Restricted Maximum Likelihood Estimation,
implemented as REML in BOLT.
To test the impact of including lower-frequency SNPs in the
heritability estimates, we constructed an additional GRM iden-
tically as we had for association testing but including no MAF
threshold. This GRM included ∼1.7M SNPs. Heritability analyses
were calculated identically using this GRM and REML in BOLT.
To calculate whether heritability estimates in men and
women were sex-dimorphic, we used the following equation
to generate a z-score:
z = h
2
females − h2males√
variancefemales + variancemales
(2)
We then converted the z-scores to P-values using the fol-
lowing formula in the statistical programming language and
software suite R (version 3.4):
p = 2∗pnorm (−abs(z)) (3)
Comparison of WHRadjBMI-associated SNPs in other
fat distribution phenotypes
Comparison with body fat percentage. Similarly to Shungin et al.
(5), we carried out analysis on the 346 index SNPs and their asso-
ciationwith BF% andWHR.We obtained association statistics for
the 346 SNPs on BF% and WHR from a GWAS of 443 001 unre-
lated European-ancestry UK Biobank individuals. We aligned
all results to the WHR-increasing allele and used a Bonferroni-
corrected P-value (0.05/346 = 1.44 × 10−4) to determine if an
SNP was associated with BF% (Fig. 2). To determine whether sex-
specific WHRadjBMI index SNPs have an adiposity phenotype,
we took the 97 (female-specific) and 8 (male-specific) SNPs and
independently compared their effects on WHRadjBMI and BF%
in men and women. To identify which sex-dimorphic SNPs were
strongly associated with BF% in men and women separately,
we used a Bonferroni-corrected P-value of 0.05/105 (4.8 × 10−4)
(Supplementary Material, Fig. 7 and Supplementary Material,
Table 9). We obtained Pearson’s r correlations using the cor()
function in R for each comparison.
Comparison with genome-wide analysis of depot-specific traits.
Recently, Chu et al. (21) performed a GWAS of subcutaneous
and ectopic fat depots, as measured by CT and MRI, in a
multi-ancestry sample. Since the meta-analysis results are
publicly available (https://grasp.nhlbi.nih.gov/FullResults.aspx
and Supplementary Material, Information for further details),
we took the index SNPs from our WHRadjBMI meta-analyses
(combined sample as well as sex-specific), checked for allele
consistency, aligned effects to the reference allele and tested for
associations with the imaging-based measures of subcutaneous
and ectopic fat. We repeated these analyses in men and women
separately. The depots investigated in the imaging-based GWAS
were pericardial tissue (PAT), PAT adjusted for height andweight,
subcutaneous adipose tissue (SAT), SAT Hounsfield units as
measured by MRI, visceral adipose tissue (VAT), VAT Hounsfield
units, ratio of VAT to SAT and VAT adjusted for BMI.
We calculated Pearson’s r correlations between z-scores in
WHRadjBMI (calculated by dividing the SNP beta by the standard
error) and SNP z-scores reported in Chu et al. (21). We evaluated
significance of the correlation by performing a t-test (imple-
mented as cor.test() in R). Correlations were considered signifi-
cant if P-value< 0.05/3 sample groups/9 phenotypes= 1.9× 10−3.
Supplementary Material
Supplementary Material is available at HMG online.
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